For instance, in small bowel neuroendocrine tumours, MCT1 expression showed no prognostic value, although Hiltunen et al. [48] indicated the absence of MCT1 positivity in lymph node metastasis tissues, suggesting that only MCT1-negative cells were prone to develop metastasis. Here, SLC16A1 is linked to small intestine neuroendocrine neoplasm.